RedCarpetLife
2609
In the world today
Cheng Zhenghui

Cheng Zhenghui

C. Zhenghui
-0.09% | - $-1.39M
$1.53 B ₹ 14,813 Cr
Real Time Net Worth #2609 Ranking as of 20 May 2026 By Forbes

More on Cheng Zhenghui

Gender

Male

Age

66Y

Country

China

Born On

January, 1960

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

No

Entrepreneur Type

Family Wealth

Primary Organization

Unknown

Titles

Unknown

Sources of Wealth

Shanghai RAAS

Industry

Pharmaceuticals, Healthcare

About Cheng Zhenghui


C heng Zhenghui is a Chinese billionaire whose fortune is derived from his family's stake in Shanghai RAAS Blood Products, a leading Chinese company in the blood plasma industry. Blood products, such as albumin and immunoglobulin, are essential for treating a variety of medical conditions, including immune disorders and shock. The company is a key player in this critical part of the healthcare sector.

The company was founded by a Vietnamese-American, but the Cheng family, along with other investors, are now the main shareholders. The company has grown by expanding its network of plasma collection centers and its manufacturing capacity. The demand for blood products in China is immense and growing, and as a leader in this highly regulated industry, Shanghai RAAS has achieved a significant valuation on the Shenzhen Stock Exchange, which is the source of the family's wealth.

Advertisement

Quick Reads


  • A major shareholder of Shanghai RAAS Blood Products.
  • The company is a leading Chinese producer of plasma-derived medicines.
  • His family is one of the controlling shareholders of the publicly listed company.
  • The blood products industry is a critical and highly regulated part of China's healthcare system.
  • His wealth is tied to the valuation of the company on the Shenzhen Stock Exchange.

Early Life and Background


Cheng Zhenghui is a Chinese businessman and the founder and Chairman of APT Medical (APT), a leading manufacturer and supplier of interventional medical devices. His wealth is rooted in the high-growth, specialized sector of cardiovascular and cerebrovascular medicine. APT is headquartered in the southern Chinese business hub of Shenzhen.

His career is defined by his commitment to medical technology and the development of sophisticated, minimally invasive tools. Cheng Zhenghui founded the company in 2002, recognizing the immense need for domestic production of high-quality, specialized catheters and medical devices, a market often dominated by international firms. His vision was to advance interventional medicine utilizing local technologies and innovations.

Career Journey of Cheng Zhenghui


Cheng Zhenghui founded APT Medical (formerly Shenzhen Huitai Medical Devices) in 2002. His strategic vision was to build a company committed to advancing interventional medicine through the development of essential medical devices, particularly focusing on electrophysiology (EP) and vascular intervention (cardiovascular and cerebrovascular). This specialization allowed APT to quickly gain market credibility.

The company successfully scaled its product portfolio—including 3D mapping systems, mapping catheters, and ablation catheters—by collaborating closely with clinicians, hospitals, and academic institutions. The culmination of this growth was APT Medical's successful IPO on the Shanghai Stock Exchange (SSE) in 2021, securing Cheng's multi-billion dollar fortune. APT is now a major supplier, exporting its specialized tools to over 90 countries and achieving a high compound annual growth rate.

Advertisement

Cheng Zhenghui's Timeline


2002:

Founds APT Medical (Shenzhen Huitai Medical Devices) (Founding).

Ongoing:

Drives the company's focus on electrophysiology and vascular intervention devices (Strategic Focus).

2021:

APT Medical executes its successful IPO on the Shanghai Stock Exchange (Financial Milestone).

Ongoing:

Continues as Chairman, guiding the company's global expansion (Executive Leadership).

Major Business Ventures and Investments


Cheng Zhenghui's wealth is concentrated in his founding equity and continued executive leadership of the publicly listed medical device giant, APT Medical (SSE: 688617).

  • APT Medical (Founder & Chairman): The core asset, a major manufacturer and supplier of electrophysiology (EP) and vascular intervention medical devices, specializing in tools for cardiology and neurointervention.
  • Medical Technology Focus: The company’s success is built on its mastery of minimally invasive interventional medical devices (e.g., specialized catheters).
  • Global Reach: APT exports its products to over 90 countries, demonstrating significant international market penetration.
  • Strategic Growth: The company successfully raised capital through its 2021 IPO to fund continuous expansion and R&D.

Advertisement

Philanthropy and Social Impact


Cheng Zhenghui's social impact is massive and humanitarian, stemming from APT Medical's role in advancing interventional medicine. His company provides essential, high-quality medical devices (catheters, surgical tools) that allow healthcare professionals to confidently tackle complex cardiovascular and cerebrovascular challenges, directly improving patient outcomes globally.

The company's commitment to innovation rooted in clinical needs is a structural contribution to medical advancement. His personal philanthropy supports medical research and community health initiatives.

Fashion, Style, and Lifestyle


Cheng Zhenghui maintains the professional, composed style of a Chinese medical technology executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic is one of serious authority and stability, befitting a multi-billion dollar executive commanding a crucial part of the global medical supply chain.

Residing in Shenzhen, his luxury is the immense security and financial reward derived from his dominance in a crucial, high-tech industrial sector. His life is defined by his commitment to technical precision and advancing human health through specialized medical devices.

Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is the founder and Chairman of APT Medical, a major supplier of interventional medical devices.
  • The company specializes in electrophysiology (EP) and vascular intervention (cardiovascular).
  • APT Medical successfully executed its IPO on the Shanghai Stock Exchange in 2021.
  • The company collaborates closely with clinicians, hospitals, and academic institutions.
  • His products are used in over 90 countries.
  • APT's portfolio includes 3D mapping systems and ablation catheters.
  • He is a major shareholder, with his wealth tied to the success of the medical technology sector.

Advertisement

More Profiles


Seth Klarman

+15.28% | +$199.47M

Jonathan Gray

+1.42% | +$112.00M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content